H Gabra

No ORCID on file · 2 papers in corpus

case-report 2016

Response to sunitinib (Sutent) in chemotherapy refractory clear cell ovarian cancer

Gynecologic oncology reports ·doi:10.1016/j.gore.2016.11.001

•Case describes a response to sunitinib in clear cell ovarian cancer.•Discussion of unique molecular characteristics of clear cell ovarian cancers•Practical points regarding dosing and toxicity when using sunitinib discussed.

observational 2005

WWOX mRNA expression profile in epithelial ovarian cancer supports the role of WWOX variant 1 as a tumour suppressor, although the role of variant 4 remains unclear

International journal of oncology ·doi:10.3892/ijo.26.6.1681

WWOX is a candidate tumour suppressor gene that exhibits LOH or homozygous deletion in several tumour types. As well as the predominant full-length transcript (variant 1) there also exist alternatively spliced transcripts found previously o…